Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study.

ABSTRACT:

SUBMITTER: Oshi M 

PROVIDER: S-EPMC12789160 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature